Delivery Order SPE2DR25D2216-SPE2DR26F7US4
- Not listed
- The Defense Logistics Agency awarded a $11,391.80 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion date of June 6, 2025. This non-set-aside contract represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated SPE2DX and running through December 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,534.77 for Shingrix vial kits, with a completion date of December 3, 2025. This competitive award, issued December 2, 2025, represents a firm fixed price delivery order with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine indicated for prevention of herpes zoster and...
- The Defense Logistics Agency (DLA) awarded a $1,102.87 delivery order to AmerisourceBergen Drug Corp for Shingrix vaccine vial kits, with an ultimate completion date of November 19, 2025. This competitively awarded, firm fixed-price contract was issued on November 18, 2025, with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine indicated for the prevention of...
- The Defense Logistics Agency awarded a $15,032.22 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of April 25, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is listed as Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits valued at $8,769.12, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is AmerisourceBergen's...
- The Defense Logistics Agency awarded a $5,652.56 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with a completion deadline of December 16, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the vendor's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $2,278.36 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 16, 2025, with completion targeted for July 17, 2025. This competitively awarded, firm fixed price delivery order represents a small-value pharmaceutical procurement executed through AmerisourceBergen's existing contract vehicle with DLA. The work will be performed at the contractor's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant...
- The Defense Logistics Agency awarded a $14,012.49 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of August 18, 2025. This contract represents a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $11,389.57 to supply Shingrix vial kits with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Shingrix is a recombinant zoster vaccine used for the prevention of herpes zoster (shingles) and is a critical pharmaceutical product...
- The Defense Logistics Agency awarded a delivery order valued at $3,417.54 to AmerisourceBergen Drug Corp for Shingrix vial kits on July 28, 2025, with completion expected by July 29, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. Shingrix is a recombinant zoster vaccine used...
- SPE2DR25D2216Indefinite Delivery Contract
- SPE2DR25D2216-SPE2DR26F7US4Delivery Order
The Defense Logistics Agency awarded a $6,617.22 delivery order to AmerisourceBergen Drug Corp for Shingrix vial kits, with an ultimate completion date of December 22, 2025. This non-set-aside, firm fixed-price contract represents a single delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. Shingrix is a recombinant zoster vaccine indicated for the prevention of herpes zoster and its complications in adults, making this procurement consistent with the federal government's vaccine supply chain requirements for military and veteran healthcare systems. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a primary pharmaceutical distributor for federal medical procurement through its comprehensive IDC with DLA. The company maintains significant capacity to fulfill diverse pharmaceutical and medical supply requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order exemplifies the operational flexibility of the underlying IDC vehicle, enabling AmerisourceBergen to respond to specific federal healthcare commodity needs on a delivery order basis with established pricing mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 12/18/25 |